Patients given semaglutide – the key ingredient in Ozempic and Wegovy – were less likely to progress to kidney failure or need transplants in what has been hailed a ‘game-changer’.Patients given semaglutide – the key ingredient in Ozempic and Wegovy – were less likely to progress to kidney failure or need transplants in what has been hailed a ‘game-changer’.Read MoreHealth News | Mail Online